🧬 Genetic Disorder

Hyper IgM Syndrome

Also known as: HIGM, CD40 Ligand Deficiency, X-linked Hyper IgM Syndrome, Autosomal Hyper IgM Syndrome

Hyper IgM syndrome is a group of rare genetic disorders characterized by a defect in the immune system, specifically affecting the ability of B cells to switch from producing IgM antibodies to other types of antibodies such as IgG, IgA, and IgE. This leads to elevated levels of IgM in the blood and a deficiency in other antibody types, making affected individuals highly susceptible to infections, particularly opportunistic infections.

ICD-10: D80.3 Orphanet: 428 OMIM: 308230
👥 1 in 1,000,000 Prevalence
🔬 15 Active Trials

Imagine your body's army (immune system) can only make one type of weapon (IgM antibodies) and can't switch to making other important weapons (IgG, IgA). This makes it hard to fight off infections, so doctors give you extra weapons (antibodies) and medicine to help.

Signs & Symptoms

  • Recurrent respiratory infections (pneumonia, sinusitis, bronchitis)
  • Opportunistic infections (Pneumocystis jirovecii pneumonia, Cryptosporidium parvum infection)
  • Chronic diarrhea
  • Failure to thrive
  • Neutropenia
  • Thrombocytopenia
  • Hepatitis
  • Encephalopathy
  • Increased susceptibility to autoimmune disorders

Treatment Options

MEDICATION FDA Approved

Immunoglobulin Replacement Therapy (IVIG or SCIG)

HIGHLY EFFECTIVE
MEDICATION FDA Approved

Prophylactic Antibiotics (e.g., trimethoprim/sulfamethoxazole)

HIGHLY EFFECTIVE
GENE THERAPY

Hematopoietic Stem Cell Transplantation (HSCT)

HIGHLY EFFECTIVE
MEDICATION FDA Approved

Granulocyte Colony-Stimulating Factor (G-CSF)

MODERATELY EFFECTIVE
GENE THERAPY

Gene Therapy

EXPERIMENTAL
SUPPORTIVE

Supportive Care (nutritional support, management of complications)

SUPPORTIVE

Diagnosis

  • Serum immunoglobulin levels (elevated IgM, low IgG, IgA, and IgE)
  • Flow cytometry to assess CD40 ligand expression on T cells (for X-linked HIGM)
  • Genetic testing to identify specific gene mutations
  • Lymph node biopsy
  • Complete blood count (CBC) to assess neutrophil and platelet counts
  • T-cell function tests

History

The first description of Hyper IgM syndrome was in the 1960s. The genetic basis of the X-linked form (CD40L deficiency) was identified in the early 1990s, leading to a better understanding of the disease mechanism and improved diagnostic and therapeutic approaches.

Recent Breakthroughs

2022

Gene Therapy for X-linked Hyper IgM Syndrome Shows Promise

Early phase clinical trials of gene therapy for X-linked Hyper IgM syndrome have demonstrated promising results, with some patients achieving sustained immune reconstitution and reduced need for immunoglobulin replacement therapy.

2023

Improved Outcomes with Early Hematopoietic Stem Cell Transplantation

A retrospective study showed that early hematopoietic stem cell transplantation (HSCT) in patients with Hyper IgM syndrome is associated with improved long-term survival and reduced risk of complications compared to delayed HSCT.